Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.03 – $0.05
3% from low
Exchange
OTC Link
OS
Borrow rate
0.64%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $43.9K | $836.2K | $2.1M |
| Cost of revenue | $0 | $0 | $34.3K | $1.1K | $390.2K | $245.2K | $1.7M |
| Gross profit | $0 | $0 | −$43.4K | −$1.1K | −$346.3K | $591.0K | $345.8K |
| Gross margin | — | — | — | — | -788.2% | 70.7% | 16.9% |
| R&D | $265 | $0 | $0 | $127.4K | $172.7K | $0 | $0 |
| Operating income | −$183.0K | −$1.5M | −$4.6M | −$1.9M | −$1.6M | −$1.5M | −$727.2K |
| EBITDA | $740.0K | −$153.0K | −$4.6M | −$1.3M | −$1.4M | −$1.2M | −$470.6K |
| Net income | −$56.1K | −$153.0K | −$11.3M | −$2.2M | −$1.6M | −$2.7M | −$617.4K |
| Net margin | — | — | — | — | -3617.0% | -317.7% | -30.1% |
| EPS (diluted) | -0.01 | -0.06 | -0.24 | -0.04 | -0.03 | -0.04 | -0.00 |
Annual figures · source: Financial Modeling Prep
GLOW LIFETECH CORP
No one on the platform currently holds GLWLF.
No tracked institution reports a position in GLWLF as of their last filing.
No one on the platform has traded GLWLF yet.
| $657242 |
| — |
| CUBTCurative Biotechnology, Inc. | $1.20 | +32.23% | $8M | — |
| KNBIFKane Biotech Inc. | $0.02 | +0.00% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.